Safety and immunogenicity of a randomized phase I prime-boost trial with ALVAC-HIV (vCP205) and gp160 MN/LAI-2 adjuvanted in alum or polyphosphazene.

Autor:	O'Connell, R. J.1, Polonis, V. R.1, Ratto-Kim, S.1, Cox, J.2, Jagodzinski, L. L.1, Malia, J.1, Michael, N. L.1, Excler, J.1, Robb, M. L.1, J. H. Kim1
Zdroj:	Retrovirology. 2012 Supplement, Vol. 9 Issue Suppl 2, p1-1. 1p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu